Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

SIMULECT basiliximab (rmc) 20mg powder for injection vial (440470)

ARTG ID

440470

ARTG Name

SIMULECT basiliximab (rmc) 20mg powder for injection vial

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

October 22, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Novartis Pharmaceuticals Australia Pty Ltd

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

Product Information

Product Information

https://medical-cdn.nocode.com/drug_tga/564cad3a2e212fdfae77ece23f74d236.pdf

Active Ingredients

Ingredient Name

Basiliximab

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

SIMULECT basiliximab (rmc) 20mg powder for injection vial (440470) - TGA 批准文号 | MedPath